Singular Genomics Systems, Inc. (OMIC) Reports In-Line Q4 EPS

Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $829.67 thousand.

For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Greene County Bancorp (GCBC) Tops Q2 EPS by 67c
• Utah Medical Products (UTMD) Tops Q2 EPS by 84c